AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Jun 3, 2015
29828_dirs_2015-06-03_d489d645-874b-445c-9af6-2033696d5bfb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-06-01
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-01 | Common Stock | M | 4375 | $23.60 | Acquired | 147797 | Direct |
| 2015-06-01 | Common Stock | M | 10625 | $23.755 | Acquired | 158422 | Direct |
| 2015-06-01 | Common Stock | S | 8956 | $113.1426 | Disposed | 149466 | Direct |
| 2015-06-01 | Common Stock | S | 6044 | $114.3063 | Disposed | 143422 | Direct |
| 2015-06-01 | Common Stock | S | 1000 | $113.354 | Disposed | 142422 | Direct |
| 2015-06-01 | Common Stock | S | 1000 | $114.3644 | Disposed | 141422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-01 | Non-Qualified Stock Option (right to buy) | $23.60 | M | 4375 | Disposed | 2019-01-21 | Common Stock (4375) | Direct |
| 2015-06-01 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 10625 | Disposed | 2020-01-28 | Common Stock (10625) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $112.72 to $113.7022. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $113.73 to $114.71. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $112.89 to $113.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $114.04 to $114.6484. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.